Cargando…

Thyroid hormone plus dual-specificity phosphatase-5 siRNA increases the number of cardiac muscle cells and improves left ventricular contractile function in chronic doxorubicin-injured hearts

Rationale: Doxorubicin is a widely used anticancer drug. However, its major side effect, cardiotoxicity, results from cardiomyocyte loss that causes left ventricle (LV) wall thinning, chronic LV dysfunction and heart failure. Cardiomyocyte number expansion by thyroid hormone (T3) during preadolescen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Lin, Bogush, Nikolay, Naqvi, Emmen, Calvert, John W., Graham, Robert M., Taylor, W. Robert, Naqvi, Nawazish, Husain, Ahsan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978295/ https://www.ncbi.nlm.nih.gov/pubmed/33754028 http://dx.doi.org/10.7150/thno.57456

Ejemplares similares

Remuscularization with triiodothyronine and β(1)-blocker therapy reverses post-ischemic left ventricular dysfunction and adverse remodeling
por: Bogush, Nikolay, et al.
Publicado: (2022)

Redox activation of JNK2α2 mediates thyroid hormone-stimulated proliferation of neonatal murine cardiomyocytes
por: Tan, Lin, et al.
Publicado: (2019)

DUSP5 expression in left ventricular cardiomyocytes of young hearts regulates thyroid hormone (T3)-induced proliferative ERK1/2 signaling
por: Bogush, Nikolay, et al.
Publicado: (2020)

Comparative regenerative mechanisms across different mammalian tissues
por: Iismaa, Siiri E., et al.
Publicado: (2018)

Mechanism-Based Cardiac Regeneration Strategies in Mammals
por: Naqvi, Nawazish, et al.
Publicado: (2021)

Role of DJ‐1 in Modulating Glycative Stress in Heart Failure
por: Shimizu, Yuuki, et al.
Publicado: (2020)

Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023)

Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
por: Butowska, Kamila, et al.
Publicado: (2023)

Haemonchus contortus: siRNA mediated knockdown of matrix metalloproteinase 12A (MMP-12) results in reduction of infectivity
por: Naqvi, Muhammad Ali-ul-Husnain, et al.
Publicado: (2020)

Doxorubicin combined with Notch1-targeting siRNA for the treatment of gastric cancer
por: Zhou, Wei, et al.
Publicado: (2018)

Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers
por: Gauthier, Florian, et al.
Publicado: (2020)

Impact of Lymphangiogenesis on Cardiac Remodeling After Ischemia and Reperfusion Injury
por: Shimizu, Yuuki, et al.
Publicado: (2018)

Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
por: Oh, Hea Ry, et al.
Publicado: (2016)

Exercise training provides cardioprotection by activating and coupling endothelial nitric oxide synthase via a β(3)-adrenergic receptor-AMP-activated protein kinase signaling pathway
por: Barr, Larry A., et al.
Publicado: (2017)

Cardiac hypertrophy limits infarct expansion after myocardial infarction in mice
por: Iismaa, Siiri E., et al.
Publicado: (2018)

Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin
por: Zou, Seyin, et al.
Publicado: (2012)

siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells
por: Dong, Xuejun, et al.
Publicado: (2009)

Polyethylenimine-Conjugated Hydroxyethyl Cellulose for Doxorubicin/Bcl-2 siRNA Co-Delivery Systems
por: Park, Jiwon, et al.
Publicado: (2023)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

Identification of Kinases and Phosphatases That Regulate ATG4B Activity by siRNA and Small Molecule Screening in Cells
por: Pengo, Niccolo, et al.
Publicado: (2018)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia, Yu, et al.
Publicado: (2017)

siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
por: Zheng, Shuquan, et al.
Publicado: (2018)

Redox/pH-Responsive 2-in-1 Chimeric Nanoparticles for the Co-Delivery of Doxorubicin and siRNA
por: Wu, Hsi-Chin, et al.
Publicado: (2021)

Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells
por: Chen, Li, et al.
Publicado: (2023)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer
por: Lo, Yi-Wen, et al.
Publicado: (2015)

Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA
por: Yoon, Hong Yeol, et al.
Publicado: (2014)

Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
por: Zhang, Jianxu, et al.
Publicado: (2017)

Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
por: Chen, Mengchun, et al.
Publicado: (2019)

Carbon Dots-Based Nanozyme for Drug-Resistant Lung Cancer Therapy by Encapsulated Doxorubicin/siRNA Cocktail
por: Yu, Hailing, et al.
Publicado: (2023)

Lipopolyplex-Mediated Co-Delivery of Doxorubicin and FAK siRNA to Enhance Therapeutic Efficiency of Treating Colorectal Cancer
por: Debele, Tilahun Ayane, et al.
Publicado: (2023)

Inhibition of MMP-2 Expression with siRNA Increases Baseline Cardiomyocyte Contractility and Protects against Simulated Ischemic Reperfusion Injury
por: Lin, Han-Bin, et al.
Publicado: (2014)

Therapeutic siRNA: Principles, Challenges, and Strategies
por: Gavrilov, Kseniya, et al.
Publicado: (2012)

pH-sensitive CAP/SiO(2) composite for efficient co-delivery of doxorubicin and siRNA to overcome multiple drug resistance
por: Cai, Zheng, et al.
Publicado: (2020)

Is green investment different from grey? Return and volatility spillovers between green and grey energy ETFs
por: Rizvi, Syed Kumail Abbas, et al.
Publicado: (2021)

Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
por: Cuellar, Trinna L., et al.
Publicado: (2015)

Amphiphilic Peptides for Efficient siRNA Delivery
por: Mozaffari, Saghar, et al.
Publicado: (2019)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_pch17qnnp80m8rgpc34ac8s00k